Related Experiment Video
Updated: Jun 17, 2025
Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
Published on: January 10, 2025
Bridging the gap in cardiac mass diagnosis: Advanced imaging, genetic associations, and biomarkers
1School of Medicine, School of Medicine, Zhejiang University, China, Hangzhou 310000, Zhejiang Province, China.
Insights
Primary cardiac tumors are rare and often linked to genetic syndromes, necessitating genetic evaluation. Differentiating these from thrombi requires a multidisciplinary approach integrating imaging and biomarkers.
Area of Science:
- Cardiology
- Oncology
- Genetics
Background:
- Primary cardiac tumors are rare due to cardiomyocyte inability to divide.
- These tumors are frequently associated with genetic mutations and syndromes.
- Distinguishing cardiac masses from thrombi and vegetations poses a diagnostic challenge.
Discussion:
- Genetic mutations and syndromes are crucial considerations in primary cardiac tumor diagnosis.
- Contrast-enhanced cardiac magnetic resonance imaging offers high sensitivity for differential diagnosis.
- Biomarkers, such as D-dimer levels, can aid in differentiating cardiac masses, particularly thrombi.
Key Insights:
- Genetic factors play a significant role in the etiology of primary cardiac tumors.
- Advanced imaging and biomarker analysis are essential for accurate cardiac mass diagnosis.
- A comprehensive diagnostic strategy is vital for managing cardiac masses.
Outlook:
- Further research into genetic markers for cardiac tumors could improve early detection.
- Integration of multi-omics data may enhance diagnostic accuracy for cardiac masses.
- Personalized medicine approaches incorporating genetic profiles will be key in managing cardiac tumors.
Abstract:
In this editorial we comment on the article by Huffaker et al published in a recent issue of the World Journal of Clinical Cases. We focus on cardiac tumors linked to genetic syndromes and the differential diagnosis of cardiac masses. As cardiomyocytes lack the ability to actively divide, primary cardiac tumors are extremely rare across all ethnicities and age groups. Once they occur, these tumors are often associated with genetic mutations and, occasionally, genetic syndromes. This underscores the importance of considering genetic mutations and syndromes when encountering these cases. The more common growths in the heart are thrombi and vegetations, which can mimic tumors, further making the differential diagnosis challenging. Among the imaging techniques, contrast-enhanced cardiac magnetic resonance imaging has the highest sensitivity for differential diagnosis. To aid in the differential diagnosis of cardiac masses, especially thrombi, appropriate utilization of biomarkers (i.e. D-dimer level) may provide pivotal clinical implications. Employing a multidisciplinary approach that integrates personal history, epidemiological insights, imaging findings, genetic markers, and biomarkers is therefore critical in the diagnostic process of cardiac masses.
